$GHDX News 4 stocks with charts pointing higher 6:58

New Post Public Reply Private Reply Replies (0) Message Board

Apr 17, 2014 at 12:37 PM

$GHDX News

4 stocks with charts pointing higher 6:58 a.m. Oct. 2, 2012 - The Trading Deck
Genomic Health up 15% on business update, earnings 10:52 a.m. Aug. 9, 2012 - Val Brickates Kennedy
Stocks to watch Tuesday: Kenexa, Coinstar, ViaSat 7:51 a.m. Feb. 7, 2012 - MarketWatch
Biotech analysts lukewarm on diagnostic stocks 4:16 p.m. Sept. 29, 2011 - Val Brickates Kennedy
Updates, advisories and surprises 7:01 p.m. Nov. 9, 2010 - MarketWatch
Genomic Health soars as drug indexes ease 12:14 p.m. Nov. 9, 2010 - Val Brickates Kennedy
Genomic Health rockets as drug indexes ease 11:14 a.m. Nov. 9, 2010 - Val Brickates Kennedy
Setting up to retest the 2008 lows 9:27 a.m. Sept. 11, 2008 - Michael Ashbaugh
Genomic Health up 4.4% at $17.48 9:40 a.m. March 27, 2007 - Tomi Kilgore
Genomic Health upped to outperform at Piper Jaffray 7:36 a.m. March 27, 2007 - Tomi Kilgore
Updates, advisories and surprises 11:01 p.m. Feb. 7, 2007 - MarketWatch
Wednesday's biggest stock gainers and decliners 7:26 p.m. Feb. 7, 2007 - Michael Baron
Genomic Health shares fall as loss widens in fourth quarter 11:32 a.m. Feb. 7, 2007 - Gabriel Madway
Genomic Health shares fall on Q4 results 11:27 a.m. Feb. 7, 2007 - Gabriel Madway
Genomic Health shares dwon 7.9% at $19.79 11:27 a.m. Feb. 7, 2007 - Gabriel Madway
Wednesday's biggest stock gainers and decliners 7:00 p.m. Jan. 17, 2007 - Michael Baron
Drug stocks rise, but Isis slides on note offering 5:35 p.m. Jan. 17, 2007 - Val Brickates Kennedy
Genomic Health down 9.9% at $21.33 10:48 a.m. Jan. 17, 2007 - Tomi Kilgore
Genomic Health cut to equal weight at Lehman Bros. 10:26 a.m. Jan. 17, 2007 - Tomi Kilgore
Wednesday's biggest stock gainers and decliners 5:56 p.m. Jan. 10, 2007 - Michael Baron

Balanced View on Genomic Health - Analyst Blog 3:20 p.m. April 8, 2014 - Zacks.com
Genomic Health, Inc. (GHDX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. April 4, 2014 - Zacks.com
Bear of the Day: Genomic Health (GHDX) - Bear of the Day 4:09 a.m. April 3, 2014 - Zacks.com
Genomic Health Unveils Oncotype DX Data - Analyst Blog 6:15 p.m. March 20, 2014 - Zacks.com
Foundation Medicine Lockup Expiration Could Flood The Market, Depressing Share Price 12:57 p.m. March 13, 2014 - Seeking Alpha
Fountain Medicine Lockup Expiration Could Flood The Market, Depressing Share Price 12:57 p.m. March 13, 2014 - Seeking Alpha
10-K: GENOMIC HEALTH INC 4:44 p.m. March 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Zacks Rank #5 Additions for Thursday - Tale of the Tape 10:30 a.m. Feb. 27, 2014 - Zacks.com
5 Biotechnology Stocks to Sell Now 3:15 a.m. Feb. 19, 2014 - InvestorPlace.com
What Makes Genomic Health (GHDX) a Strong Sell? - Tale of the Tape 9:45 a.m. Feb. 13, 2014 - Zacks.com
Weakness seen in Genomic Health (GHDX): Stock Tumbles 9.0% - Tale of the Tape 9:43 a.m. Feb. 6, 2014 - Zacks.com
Q4 Loss Narrower Than Expected at Genomic, Revs Up Y/Y - Analyst Blog 11:30 a.m. Feb. 5, 2014 - Zacks.com
UPDATE: Bank of America Reiterates on Genomic Health as 2014 Outlook is Below Expectations 10:15 a.m. Feb. 5, 2014 - benzinga.com
Genomic Health Management Discusses Q4 2013 Results - Earnings Call Transcript 9:10 p.m. Feb. 4, 2014 - Seeking Alpha
Q4 2013 Genomic Health Inc Earnings Conference call (Webcast) 5:25 p.m. Feb. 4, 2014 - Seeking Alpha
A New Approach to Prostate Cancer 8:12 p.m. Jan. 13, 2014 - The Wall Street Journal Interactive Edition
MannKind Corp. (MNKD) Surges: Stock Moves 18.4% Higher - Tale of the Tape 10:21 a.m. Jan. 10, 2014 - Zacks.com
InterMune (ITMN) Jumps: Stock Rises 9.5% - Tale of the Tape 9:57 a.m. Jan. 10, 2014 - Zacks.com
Agenus (AGEN) Jumps: Stock Adds 8.8% in Session - Tale of the Tape 9:51 a.m. Jan. 10, 2014 - Zacks.com
Cytori Therapeutics (CYTX) Soars: Stock Adds 11.4% in Session - Tale of the Tape 10:21 a.m. Jan. 9, 2014 - Zacks.com

Genomic Health Announces Presentation of New Data Further Supporting Use of Oncotype DX® in Europe 8:00 a.m. March 19, 2014 - PR Newswire - PRF
Genomic Health Announces Year-End 2013 Financial Results, Provides 2014 Financial Outlook 5:01 p.m. Feb. 4, 2014 - PR Newswire - PRF
Genomic Health Announces Results of Oncotype DX® Colon Cancer Studies Presented at 2014 American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI) Symposium 9:00 a.m. Jan. 29, 2014 - PR Newswire - PRF
Genomic Health to Announce Fourth Quarter and Year-End 2013 Financial Results and Host Conference Call on Tuesday, February 4, 2014 9:00 a.m. Jan. 28, 2014 - PR Newswire - PRF
Specialised Therapeutics Australia Partners with Genomic Health Inc. to Deliver Novel Genomic Test to Breast Cancer Patients 9:00 a.m. Jan. 7, 2014 - PR Newswire
Genomic Health Announces Presentation at J.P. Morgan Healthcare Conference 5:00 p.m. Jan. 6, 2014 - PR Newswire
Healthcare Companies Announce Study Results, Acquisitions and Company Updates - Research Report on Sirona Dental Systems, Ligand Pharmaceuticals, Genomic Health, Unilife, and Sykes 9:00 a.m. Dec. 24, 2013 - PR Newswire
Quarterly Dividends, Clinical Trial Results, Dental Exhibition Updates, and Upcoming Presentation Schedules - Research Report Quest Diagnostics, Avanir, Sirona, Ligand and Genomic Health 9:00 a.m. Dec. 16, 2013 - PR Newswire
Genomic Health Announces Presentation of New Oncotype DX® Studies Underscoring Unique Value of the Test in Early-Stage Breast Cancer at the 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium 9:35 a.m. Dec. 14, 2013 - PR Newswire
Invitae Offers BRCA1/BRCA2 Testing, Providing Clinicians With a Reliable, Fast, Affordable Option for Patients 9:30 a.m. Dec. 11, 2013 - BusinessWire
Invitae Completes $40 Million Series E Financing 10:00 a.m. Dec. 10, 2013 - BusinessWire
Genomic Health Announces Presentation of Oncotype DX® Studies at the 2013 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) 9:00 a.m. Dec. 4, 2013 - PR Newswire
Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer 5:01 p.m. Nov. 25, 2013 - PR Newswire
Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer 5:01 p.m. Nov. 25, 2013 - BusinessWire
Genomic Health Announces Publication of Oncotype DX® Prostate Cancer Test Analytical Validation Study 9:00 a.m. Nov. 22, 2013 - PR Newswire
Applied Proteomics Appoints Premal S. Shah As Vice President Of Business Development 9:00 a.m. Nov. 19, 2013 - PR Newswire
Company Statements, Study Results, Stock Movements, Awards and Stock Splits - Research Report on WebMD, Cerner, Waters, Medidata and Genomic Health 9:00 a.m. Nov. 18, 2013 - PR Newswire
Genomic Health Announces Colon Cancer Publication in Journal of Clinical Oncology Supporting Wider Oncotype DX® Utilization 9:00 a.m. Nov. 13, 2013 - PR Newswire
Companies in the Healthcare Sector Report Financial Results, and Scheduled Conference calls - Research Report on OXiGENE, BioTelemetry, Abiomed, Emeritus, and Genomic Health 9:00 a.m. Nov. 11, 2013 - PR Newswire
Genomic Health Announces Third Quarter 2013 Financial Results and Business Progress 5:01 p.m. Nov. 5, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

VIZ Media Expands Reach with MangaPlaza Partnership

Manga Magic in the Digital Space Another day, another expansion, folks. VIZ Media's latest move to have its manga offerings available on MangaPlaza feels like a pretty shrewd play in the fierce arena of digital content. Who'd have thought decades ago that we'd be sitting here talking about digital comics like they’re the next Netflix? VIZ Media's expansion into...

BellRing Brands Lawsuit Hinges on Sales Misrepresentation

BellRing's Legal Tangle Deepens When it comes to drawing the line between having a good quarter and pulling the wool over investors' eyes, the latest lawsuit knotted up with BellRing Brands, Inc. (NYSE: BRBR) shows just how fine that line can be. This legal drama, filed on the not-so-distant date of January 22, 2026, isn't your garden-variety beef. We're talking...

Keith Strachan Elevates The Master Group's Strategy

Strachan Steps Up as Chief Commercial Officer Keith Strachan is stepping into the role of Chief Commercial Officer at The Master Group—big news up in St-Bruno-de-Montarville. Now, those not neck-deep in HVAC-R might shrug this one off, but for those eyeing the industry, this is where the cards start to shuffle in North America. Master’s shift isn't just paper-pushing;...

MPLX Adds Industry Veterans to Board Leadership

A New Era for MPLX's Board Nothing shakes up the scene like announcing two heavyweights joining the board, and that's exactly what MPLX LP (NYSE: MPLX) just pulled off. Micheal G. Dunn and Bruce L. Niemeyer are coming onboard, effective November 1, 2026. With pedigrees that could make any industry insider nod in approval, these guys bring decades of experience to the...

Webull Faces Class Action: Investor Impact Deep Dive

What's Going On with Webull? Ah, Webull Corporation, you're in the hot seat now. If you blinked on October 7th, you might have missed a monumental 19.09% cliff dive in Webull's stock, tumbling down to a humble $5.89. The roar wasn't just the market reacting; it was the sonic boom of a class action lawsuit on their heels, alleging some slick legal sledding with misleading...

Wood Partners Expands Charlotte Footprint with New Project

Charlotte's Expansion Beckons New Development at Village Park Charlotte's skyline is about to get a new neighbor in a growing district, as Wood Partners is set to break ground yet again, unveiling its ambitious plans for Village Park. This is not just a hodgepodge construction talk—it’s the company’s latest effort to plant its flag deep in the heart of the Queen...

Duolingo Lawsuit Looms Over Securities Allegations

Duolingo Lawsuit: A New Headache for Investors Seems like every time you blink, another tech darling is getting dragged to court, and now it's Duolingo's turn to face the music. They're locked in a class action lawsuit food-fight over violations of the Securities Exchange Act of 1934, specifically, §§10(b) and 20(a), and Rule 10b-5. The Core of Allegations Against...

Young Leaders Drive Be Strong’s Mental Health Movement

New Voices at the Helm Today’s youth aren’t just tomorrow's leaders; they’re stepping up now. Groups like Be Strong’s newly minted National Student Advisory Board are proving that. Sixteen kids across eleven states are diving headfirst into transforming mental health narratives. This ain't just some school club. These young guns are gearing up to reshape how we...

Historic Williamsburg Loft Gets a Modern Makeover

Breathing New Life into a Brooklyn Classic Alright, picture this: You're stepping into a century-old Brooklyn loft, expecting dust, aged wood, maybe a ghost or two. What you actually find is art wrapped in brass with a splash of modern flair. This ain't just any loft, folks—it's the latest trophy on the mantle for Gallery KBNY, a design-build firm known for its...

Cat Financial Shows Solid Q3 Growth Amid Challenges

Healthy Gains in Revenues and Profits Well, Cat Financial's latest report is another piece of the puzzle showing steady, if not spectacular, growth. They've jacked up their revenues by 10% for the third quarter of 2026 compared to last year's same stretch. This puts the revenues at $1.02 billion, a $95 million bump from the previous year. Pretty impressive. The profit saw...